Known for inventing the shift dress, Lilly Pulitzer’s Romey shift romper gives the classic style look but with ease and ...

If you're planning a spring or summer break trip to Disney World, you're definitely going to want to grab some of these ...

Showcasing a limited-edition, hand-painted print, the new collection features coordinating styles for kids and adults.

We may earn commission on some of the items you choose to buy. If you asked us, there’s never a bad season for Lilly Pulitzer’s juicy, playful, serotonin-boosting prints, but there’s no ...

A California company's dried lily flowers have been recalled because they may contain undeclared sulfites, according to the U.S. Food and Drug Administration. The FDA and Hayward, California-based ...

Apple's and Eli Lilly's plans to expand manufacturing and development in the U.S. Earning updates from Home Depot and Cava. Jason dives deeper into Axon's earnings with Axon President Josh Isner ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 33 trades. If we consider the specifics of each ...

When it comes to swapping one’s wardrobe for the warm weather, Lilly Pulitzer is often a go-to brand for bright, fun outfits perfect for going out or vacationing during spring and summertime.

Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to develop cancer drugs leveraging the company’s TrueGlue discovery platform.